Over the last decade, treatment options for lung cancer patients have evolved drastically. Even in just the last few months, promising research has led to new, approved therapies, and researchers anticipate more advances are on the way.
“Drugs are emerging at a rapid pace now,” says Geoffrey Oxnard, MD, of Dana-Farber’s Lowe Center for Thoracic Oncology. “There is a lot of optimism in lung cancer, a lot of options for patients and excitement about new things that are coming.”
Oxnard recently discussed some of these emerging therapies during a live video webchat on the latest lung cancer treatment and research, including new developments in immunotherapy and targeted therapy.
Learn more about these new treatments by watching a recording of the webchat below: